Simplex Trading, LLC Adc Therapeutics Sa Transaction History

Simplex Trading, LLC

$195 Billion
Q3 2025

A detailed history of Simplex Trading, LLC transactions in Adc Therapeutics Sa stock. As of the latest transaction made, Simplex Trading, LLC holds 8,143 shares of ADCT stock, worth $32,246. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,143

Previous 7,350 10.79%

Holding current value

$32,246

Previous $19,000 68.42%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	BUY	$2.64 - $4.02 $2,093 - $3,187	793 Added 10.79%	8,143 $32,000
Q2 2025 Aug 05, 2025	BUY	$1.1 - $3.67 $8,085 - $26,974	7,350 New	7,350 $19,000
Q4 2024 Feb 11, 2025	BUY	$1.89 - $3.48 $5,439 - $10,015	2,878 Added 119.27%	5,291 $10,000
Q3 2024 Nov 08, 2024	BUY	$2.59 - $4.01 $1,230 - $1,904	475 Added 24.51%	2,413 $7,000
Q2 2024 Jul 25, 2024	SELL	$2.55 - $5.09 $32,683 - $65,238	-12,817 Reduced 86.87%	1,938 $6,000

Q1 2024 Apr 25, 2024	BUY	$1.66 - $5.29 $22,536 - $71,817	13,576 Added 1151.48%	14,755 $66,000
Q4 2023 Feb 02, 2024	SELL	$0.47 - $1.79 $24 - $94	-53 Reduced 4.3%	1,179 $1,000
Q3 2023 Nov 01, 2023	BUY	$0.72 - $2.37 $280 - $924	390 Added 46.32%	1,232 $1,000
Q2 2023 Aug 04, 2023	BUY	$1.9 - $2.66 $1,286 - $1,800	677 Added 410.3%	842 $1,000
Q1 2023 Apr 27, 2023	SELL	$1.92 - $5.45 $4,638 - $13,167	-2,416 Reduced 93.61%	165 $0
Q4 2022 Feb 02, 2023	SELL	$2.87 - $5.24 $18,256 - $33,331	-6,361 Reduced 71.14%	2,581 $9,000
Q3 2022 Nov 04, 2022	BUY	$4.66 - $10.31 $41,669 - $92,192	8,942 New	8,942 $43,000
Q1 2022 May 02, 2022	SELL	$13.28 - $20.03 $1,181 - $1,782	-89 Closed	0 $0
Q4 2021 Feb 23, 2022	BUY	$19.29 - $31.51 $1,716 - $2,804	89 New	89 $1,000
Q2 2021 Aug 12, 2021	SELL	$20.38 - $27.04 $19,075 - $25,309	-936 Closed	0 $0
Q1 2021 Apr 26, 2021	BUY	$22.75 - $34.05 $14,355 - $21,485	631 Added 206.89%	936 $22,000
Q4 2020 Feb 02, 2021	SELL	$25.26 - $38.02 $3,359 - $5,056	-133 Reduced 30.37%	305 $9,000
Q3 2020 Oct 14, 2020	BUY	$32.87 - $51.05 $14,397 - $22,359	438 New	438 $14,000

Others Institutions Holding ADCT

# of Institutions

108

Shares Held

67.3M

Call Options Held

39.8K

Put Options Held

68.4K

View Full List

About ADC Therapeutics SA

Ticker ADCT
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,645,296
Market Cap $307M
Description
ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma;...

More about ADCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account

Simplex Trading, LLC Adc Therapeutics Sa Transaction History